1 Chinese accused of stealing American trade secret sells knockoff imitation | | commercial secrets in China _ news
Reference news, June 7, foreign media said the United States a successful cattle enterprise, Oregon court ban against a former employee. The former employees were charged with stealing commercial secrets, to set up his own company in China.
June 5, citing news of the capital, the associated press reported that headquartered in Corvallis, Oregon, Omni research firms have filed lawsuits, it says, this man named Wang Yongqiang (sound) scientists are attempting to violate a confidentiality agreement, to sell the enterprise imitation of feed additives.
United States District Court judge maikeer·maikeshaen ordered Yongqiang Wang and his wife, and the companies they control to stop using Omni research copyright material and trade secrets. This preliminary injunction, asking them to return the same Omni research all materials relating to the company's technology.
Aomunigen Research Corporation was founded in 2002. It is a professor at Oregon State University nier·fusiboge shidifu·Pang Tennyson and his graduate students was established. They developed a number of feed additives aimed at treatment of intestinal bleeding syndrome in dairy cows. Ten years later, phibro animal health Corporation Headquarters in New York for about $ 23 million were purchased by Omni.
Phibro's financial documents show that about 20% of the United States dairy cows through Omni's products have been treated, these products are also popular in other countries, and received regulatory approval in China.
Aomunigen's complaint said, Wang Yongqiang graduate student at Oregon State University, Forsberg asked him to join the company.
The petition says: "However, in some cases, the King clearly considered him no allegiance to yuaomunigen research. Therefore, while continuing to work in the Omni, breach of contract and fiduciary duty he secretly set up two companies, so that with the help of his wife and companion and aomunigen research company.
The complaint said Wang Yongqiang with Omni product ingredients in some of the same products made in China "counterfeit" patent.
The complaint said Wang Yongqiang established enterprises last year, China held a seminar on animal health, during which he produced from the Omni "illegal copies" of copyrighted material.
As a response to the petition, Yongqiang Wang denied that he tied to any trade secrets or confidential information of aomunigen for a profit. (Compilation/Jutier)
Source: references
Responsible editor: Qiao Leihua SN098
Article keywords:Imitation of trade secrets
I want feedback
Save a Web page
China News Network
1名华人被指窃取美企商业机密在中国卖仿制品|仿制品|商业机密_新闻资讯
参考消息网6月7日报道 外媒称，美国俄勒冈州一家牲畜企业成功让法院发布针对一名前雇员的禁令。该前雇员被控盗取商业机密，以在中国开办他自己的公司。
美联社6月5日援引《首都新闻报》的报道称，总部设在俄勒冈州科瓦利斯的奥姆尼根研究公司已经提起诉讼，它说，这名叫王永强（音）的科学家正试图违反保密协议，以售卖该企业饲料添加剂的仿制品。
美国地方法院法官迈克尔·麦克沙恩已经下令王永强和他的妻子，以及他们控制的企业停止使用奥姆尼根研究公司版权所有的材料和商业机密。这项初步的禁令还要求他们归还同奥姆尼根研究公司的技术有关的所有材料。
奥姆尼根研究公司成立于2002年。它是俄勒冈州立大学教授尼尔·福斯伯格和他的研究生史蒂夫·庞坦尼建立的。他们研发了一些饲料添加剂，旨在治疗奶牛的肠出血综合征。十年后，总部设在纽约的菲布罗动物卫生公司以大约2300万美元的价格收购了奥姆尼根。
菲布罗的财务文件显示，大约20%的美国奶牛通过奥姆尼根产品得到了治疗，这些产品在其他一些国家也很流行，并获得了监管机构批准以在中国销售。
奥姆尼根的诉状说，王永强在俄勒冈州立大学当研究生时，福斯伯格让他加入该企业。
该诉状说：“然而，在某些时候，王显然认为，他不必效忠于奥姆尼根研究公司。因此，虽然继续在奥姆尼根工作，他违背了合同和信托责任，秘密成立了两家企业，以便在他妻子和同伴的帮助下与奥姆尼根研究公司竞争。
该诉状说，王永强为同奥姆尼根产品成分相同的一些产品在中国取得了“假冒”专利。
该诉状说，去年王永强成立的企业在中国举行了有关牲畜卫生的一个讨论会，期间，他出示了从奥姆尼根“非法复制”的受版权保护的材料。
作为对该诉状的回应，王永强否认他依靠任何奥姆尼根的商业机密或保密信息来获利。（编译/朱捷）
来源：参考消息
责任编辑：乔雷华 SN098
文章关键词： 仿制品 商业机密
我要反馈
保存网页
中国新闻网
